Clinical and laboratory characteristics during a 1‐year follow‐up in European Lyme neuroborreliosis: A prospective cohort study
LNB can present with solely subjective symptoms, especially pain. Many LNB patients have persistent Bb antibodies in serum and CSF. In seronegative LNB, CSF Bb-PCR and CXCL13 may give diagnostic support. CXCL13 may be persistently positive after treatment in some patients. Most of the clinical improvement occurs during the first 10 weeks. High initial clinical score is associated with poorer outcome.
Authors
- Unn Ljøstad (ORCID: https://orcid.org/0000-0002-7666-1396)
- Åslaug Rudjord Lorentzen (ORCID: https://orcid.org/0000-0002-6918-4157)
- Åse Mygland (ORCID: https://orcid.org/0000-0001-9160-2805)
- Ingerid Skarstein (ORCID: https://orcid.org/0009-0006-3221-3643)
- Hanne Quarsten (ORCID: https://orcid.org/0000-0001-6469-525X)
- Randi Eikeland (ORCID: https://orcid.org/0000-0003-0104-9626)
- Anne Marit Solheim (ORCID: https://orcid.org/0000-0001-7357-6287)
- Harald Reiso (ORCID: https://orcid.org/0000-0003-4874-8707)
- Pål Berg‐Hansen (ORCID: https://orcid.org/0000-0003-0925-8879)
Institutions
- Oslo University Hospital (NO)
- University of Agder (NO)
- Haukeland University Hospital (NO)
- Sørlandet Sykehus (NO)
- University of Bergen (NO)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1111/ene.16487
- Citations
- 11
- Primary Topic
- Vector-borne infectious diseases
- Type
- article
- Field-Weighted Citation Impact
- 5.67